Skip to main content

Study

Ashwagandha May Cause Neuropsychiatric Issues in Some Adults

Taking ashwagandha supplements might lead to confusion and memory issues in rare cases, as seen in a recent study.

Study Credibility: Low3.8/10Early findingsNot enough evidence yetTalk with your clinician
PublishedFeb 2026Last reviewedFeb 2026
Email this

Summary

In plain language

A recent study explored the potential side effects of ashwagandha, a popular herbal supplement, often used for stress relief and improved sleep. The study highlighted a rare but serious case where a 40-year-old man experienced confusion, memory problems, and abnormal sleep behaviors after taking ashwagandha. While ashwagandha is generally considered safe, this case emphasizes the importance of caution, especially when taking it without medical supervision. Seniors considering ashwagandha should discuss it with their healthcare providers, especially if they are taking other medications or have existing health conditions.

Details

Use the full description to understand the study design, methods, and the limits of the findings.

This article is based on a detailed medical case report describing a possible rare side effect linked to ashwagandha.

  • Study design (in simple terms): A single-person case report. Doctors documented symptoms, timing, testing, and recovery after stopping the supplement.

  • Key findings (with numbers): Symptoms began a few hours after taking two tablets (total 500 mg). The patient slept about 23 hours and arrived confused with a 4AT delirium screening score of 10 (a high score). CT and MRI brain scans were normal. Spinal fluid testing for infections (including HSV and VZV) was negative. He improved within hours and returned to baseline by day 3. A causality tool (Naranjo scale) scored the reaction as 7 = “probable”.

  • Limitations/caveats: This is only one case, so it cannot tell us how often this happens or who is most at risk. The supplement brand and purity can vary, and an EEG (a brain-wave test) was not done. Case reports can suggest a warning signal but do not prove cause for everyone.

  • Practical implications for daily life: If you take ashwagandha, be cautious with dose increases, and watch for excessive sleepiness, vivid/strange dreams, confusion, unsteady walking, or unusual nighttime behaviors. Avoid mixing supplements with sedating medications or alcohol unless your clinician says it’s safe. If sudden confusion occurs, treat it as urgent and seek medical care.

Bring a full list of all supplements (including “natural” products) to your healthcare provider or pharmacist, especially if you take medicines for blood pressure, mood, sleep, or pain.

Research Quality Score

Scored February 16, 2026 using rubric v6_2026-02-01.

Assessment

Methodologically, this is low-level evidence (a single-person case report). Its main value is as a safety signal: it documents a plausible time-linked adverse event with a reasonably thorough clinical evaluation and symptom resolution after stopping the supplement (dechallenge), plus a structured causality assessment (Naranjo). However, it cannot establish causation, quantify risk, or rule out all confounders. For adults 60+, the topic is highly relevant (delirium risk, polypharmacy, supplement variability), but the evidence strength remains limited because conclusions rest on one case and product composition/contaminants may be uncertain without independent verification.

Category Breakdown

CategoryScoreRating
Study design2.5/10
Bias control4.0/10
Statistical methods1.0/10
Reporting completeness6.5/10
Conflicts & funding5.0/10
Replication2.0/10
Relevance to chosen population6.0/10
Journal Reliability6.0/10

Additional Notes

Conservative interpretation is warranted: case reports are prone to publication bias (unusual events are more likely to be reported) and cannot determine frequency or identify who is at risk. Product variability is a major limitation for supplement-related reports; ideally, the exact formulation, batch/lot, and independent testing would be documented. If the full text includes explicit age, comorbidities, concomitant medications (especially sedatives/anticholinergics), and formal COI/funding statements, relevance and conflicts scores could be adjusted accordingly.

Take the next step

Build a personalized plan using research-backed studies, conditions, and treatments.